Protective Effects of Cell-Free Supernatant and Live Lactic Acid Bacteria Isolated from Thai Pigs Against a Pandemic Strain of Porcine Epidemic Diarrhea Virus
- 376 Downloads
Porcine epidemic diarrhea virus (PEDV) is a coronavirus which causes severe diarrhea and fatal dehydration in piglets. In general, probiotic supplements could enhance recovery and protect piglets against enteric pathogens. Seven local lactic acid bacteria (LAB), (Ent. faecium 79N and 40N, Lact. plantarum 22F, 25F and 31F, Ped. acidilactici 72N and Ped. pentosaceus 77F) from pig feces were well-characterized as high potential probiotics. Cell-free supernatants (CFS) and live LAB were evaluated for antiviral activities by co-incubation on Vero cells and challenged with a pandemic strain of PEDV isolated from pigs in Thailand. Cell survival and viral inhibition were determined by cytopathic effect (CPE) reduction assay and confirmed by immunofluorescence. At 1:16, CFS dilution (pH 6.3–6.8) showed no cytotoxicity in Vero cells and was therefore used as the dilution for antiviral assays. The diluted CFS of all Lact. plantarum showed the antiviral effect against PEDV; however, the same antiviral effect could not be observed in Ent. faecium and Pediococcus strains. In competitive experiment, only live Lact. plantarum 25F and Ped. pentosaceus 77F showed CPE reduction in the viral infected cells to <50% observed field area. This study concluded that the CFS of all tested lactobacilli, and live Lact. plantarum (22F and 25F) and Pediococcus strains 72N and 77F could reduce infectivity of the pandemic strain of PEDV from pigs in Thailand on the target Vero cells.
KeywordsAntiviral activity Cell-free supernatants Lactic acid bacteria Porcine epidemic diarrhea virus Probiotics
This study was financially supported by The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), STAR; Diagnosis and Monitoring of Animal Pathogen, Chulalongkorn University and the Agricultural Research Development Agency (ARDA) (No. 5803090002) (Public Organization), Thailand. We thank Professor Somboon Tanasupawat for assistance and comments to improve the manuscript.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 3.Di-qiu L, Jun-wei G, Xin-yuan Q, Yan-ping J, Song-mei L, Yi-jing L (2012) High-level mucosal and systemic immune responses induced by oral administration with lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with lactobacillus-expressed N protein. Appl Microbiol Biot 93(6):2437–2446CrossRefGoogle Scholar
- 9.Chang TL-Y, Chang C-H, Simpson DA, Xu Q, Martin PK, Lagenaur LA, Schoolnik GK, Ho DD, Hillier SL, Holodniy M (2003) Inhibition of HIV infectivity by a natural human isolate of lactobacillus jensenii engineered to express functional two-domain CD4. P Natl A Sci 100(20):11672–11677CrossRefGoogle Scholar
- 14.Hofmann M, Wyler R (1988) Propagation of the virus of porcine epidemic diarrhea in cell culture. J Clin Microbiol 26(11):2235–2239Google Scholar
- 15.Reed L, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497Google Scholar
- 21.Ermolenko E, Furaeva V, Isakov V, Ermolenko D, Suvorov A (2009) Inhibition of herpes simplex virus type 1 reproduction by probiotic bacteria in vitro. Vopr Virusol 55(4):25–28Google Scholar
- 24.Yang S-C, Lin C-H, Sung CT, Fang J-Y (2014) Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol 5:241Google Scholar
- 26.Allayeh AK, Dardeer EE, Kotb NS (2015) Effects of cell-free supernatants of yogurts metabolites on Coxsackie B3 virus in vitro and in vivo. Middle East J Appl Sci 5:353–358Google Scholar
- 27.Charteris W, Kelly P, Morelli L, Collins J (1998) Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 84(5):759–768CrossRefGoogle Scholar